Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Prognosis of screen-detected heart failure with reduced and preserved ejection fraction in patients with type 2 diabetes.

Boonman-de Winter LJ, Hoes AW, Cramer MJ, de Jongh G, Janssen RR, Rutten FH.

Int J Cardiol. 2015 Apr 15;185:162-4. doi: 10.1016/j.ijcard.2015.03.120. Epub 2015 Mar 11. No abstract available. Erratum in: Int J Cardiol. 2016 Mar 1;206:174.

PMID:
25796002
2.

Trigger finger caused by anatomical variation lumbrical muscle.

Molendijk EB, de Jongh GJ.

J Hand Surg Eur Vol. 2013 Mar;38(3):325-6. doi: 10.1177/1753193412465727. Epub 2012 Nov 7. No abstract available.

PMID:
23134776
3.

Towards hospital standardization in Europe.

Shaw C, Bruneau C, Kutryba B, de Jongh G, Suñol R.

Int J Qual Health Care. 2010 Aug;22(4):244-9. doi: 10.1093/intqhc/mzq030. Epub 2010 Jun 24.

PMID:
20576789
4.

[Perineal nodular induration].

Asselbergs CP, Loeff JW, de Jongh GJ, de Winter TC.

Ned Tijdschr Geneeskd. 2009;153:A58. Dutch.

PMID:
19818180
5.

Expression of the vanin gene family in normal and inflamed human skin: induction by proinflammatory cytokines.

Jansen PA, Kamsteeg M, Rodijk-Olthuis D, van Vlijmen-Willems IM, de Jongh GJ, Bergers M, Tjabringa GS, Zeeuwen PL, Schalkwijk J.

J Invest Dermatol. 2009 Sep;129(9):2167-74. doi: 10.1038/jid.2009.67. Epub 2009 Mar 26.

6.

Beta-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin.

Jansen PA, Rodijk-Olthuis D, Hollox EJ, Kamsteeg M, Tjabringa GS, de Jongh GJ, van Vlijmen-Willems IM, Bergboer JG, van Rossum MM, de Jong EM, den Heijer M, Evers AW, Bergers M, Armour JA, Zeeuwen PL, Schalkwijk J.

PLoS One. 2009;4(3):e4725. doi: 10.1371/journal.pone.0004725. Epub 2009 Mar 6.

7.

Genetically programmed differences in epidermal host defense between psoriasis and atopic dermatitis patients.

Zeeuwen PL, de Jongh GJ, Rodijk-Olthuis D, Kamsteeg M, Verhoosel RM, van Rossum MM, Hiemstra PS, Schalkwijk J.

PLoS One. 2008 Jun 4;3(6):e2301. doi: 10.1371/journal.pone.0002301.

8.

Psoriasis is associated with increased beta-defensin genomic copy number.

Hollox EJ, Huffmeier U, Zeeuwen PL, Palla R, Lascorz J, Rodijk-Olthuis D, van de Kerkhof PC, Traupe H, de Jongh G, den Heijer M, Reis A, Armour JA, Schalkwijk J.

Nat Genet. 2008 Jan;40(1):23-5. Epub 2007 Dec 2.

9.

Increased expression of carbonic anhydrase II (CA II) in lesional skin of atopic dermatitis: regulation by Th2 cytokines.

Kamsteeg M, Zeeuwen PL, de Jongh GJ, Rodijk-Olthuis D, Zeeuwen-Franssen ME, van Erp PE, Schalkwijk J.

J Invest Dermatol. 2007 Jul;127(7):1786-9. Epub 2007 Mar 15. No abstract available.

10.

Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a reactive site that is distinct from the legumain-binding site. A novel clue for the role of cystatin M/E in epidermal cornification.

Cheng T, Hitomi K, van Vlijmen-Willems IM, de Jongh GJ, Yamamoto K, Nishi K, Watts C, Reinheckel T, Schalkwijk J, Zeeuwen PL.

J Biol Chem. 2006 Jun 9;281(23):15893-9. Epub 2006 Mar 24.

11.

High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis.

de Jongh GJ, Zeeuwen PL, Kucharekova M, Pfundt R, van der Valk PG, Blokx W, Dogan A, Hiemstra PS, van de Kerkhof PC, Schalkwijk J.

J Invest Dermatol. 2005 Dec;125(6):1163-73.

12.

Serial analysis of gene expression in human keratinocytes and epidermis.

Jansen BJ, de Jongh G, Schalkwijk J, van Ruissen F.

Methods Mol Biol. 2005;289:383-98.

PMID:
15502200
13.
14.

The human cystatin M/E gene (CST6): exclusion candidate gene for harlequin ichthyosis.

Zeeuwen PL, Dale BA, de Jongh GJ, van Vlijmen-Willems IM, Fleckman P, Kimball JR, Stephens K, Schalkwijk J.

J Invest Dermatol. 2003 Jul;121(1):65-8.

15.

The effect of the PDE-4 inhibitor (cipamfylline) in two human models of irritant contact dermatitis.

Kucharekova M, Hornix M, Ashikaga T, T'kint S, de Jongh GJ, Schalkwijk J, van de Kerkhof PC, van der Valk PG.

Arch Dermatol Res. 2003 Apr;295(1):29-32. Epub 2003 Mar 4.

PMID:
12709818
16.

Actinic keratoses in renal transplant recipients do not improve with calcipotriol cream and all-trans retinoic acid cream as monotherapies or in combination during a 6-week treatment period.

Smit JV, Cox S, Blokx WA, van de Kerhof PC, de Jongh GJ, de Jong EM.

Br J Dermatol. 2002 Oct;147(4):816-8. No abstract available.

PMID:
12366444
17.

A partial transcriptome of human epidermis.

van Ruissen F, Jansen BJ, de Jongh GJ, Zeeuwen PL, Schalkwijk J.

Genomics. 2002 May;79(5):671-8.

PMID:
11991716
18.

Differential gene expression in premalignant human epidermis revealed by cluster analysis of serial analysis of gene expression (SAGE) libraries.

van Ruissen F, Jansen BJ, de Jongh G, van Vlijmen-Willems IM, Schalkwijk J.

FASEB J. 2002 Feb;16(2):246-8. Epub 2001 Dec 28.

PMID:
11772949
19.

Serial analysis of gene expression in differentiated cultures of human epidermal keratinocytes.

Jansen BJ, van Ruissen F, de Jongh G, Zeeuwen PL, Schalkwijk J.

J Invest Dermatol. 2001 Jan;116(1):12-22.

20.

Expression of tenascin-C splice variants by human skin cells.

Latijnhouwers MA, de Jongh GJ, Bergers M, de Rooij MJ, Schalkwijk J.

Arch Dermatol Res. 2000 Sep;292(9):446-54.

PMID:
11000288
21.

Flow-cytometric characterization of normal versus psoriatic epidermis using improved cell separation methodology.

Seegers BA, Glade CP, van Hooijdonk CA, van Erp PE, de Jongh GJ, van de Kerkhof PC.

Exp Dermatol. 2000 Aug;9(4):266-70.

PMID:
10949548
22.

Topical all-trans retinoic acid does not influence minimal erythema doses for UVB light in normal skin.

Smit JV, de Jong EM, de Jongh GJ, van de Kerkhof PC.

Acta Derm Venereol. 2000 Jan-Feb;80(1):66-7. No abstract available.

PMID:
10721847
23.

Multi parameter flow cytometric assessment of regenerative epidermis with special reference to the antiproliferative effect of occlusion.

van Rossum MM, Mommers JM, van de Kerkhof PC, de Jongh GJ, van Hooijdonk CA, van Erp PE.

Anal Cell Pathol. 1998;17(3):157-65.

24.
25.

Tenascin-C expression in human epidermal keratinocytes is regulated by inflammatory cytokines and a stress response pathway.

Latijnhouwers MA, Pfundt R, de Jongh GJ, Schalkwijk J.

Matrix Biol. 1998 Aug;17(4):305-16.

PMID:
9749946
26.

Flow cytometric and microscopic characterization of the uptake and distribution of phosphorothioate oligonucleotides in human keratinocytes.

Wingens M, van Hooijdonk CA, de Jongh GJ, Schalkwijk J, van Erp PE.

Arch Dermatol Res. 1998 Mar;290(3):119-25.

PMID:
9558486
27.

Immune deficiency in familial duodenal atresia.

Moore SW, de Jongh G, Bouic P, Brown RA, Kirsten G.

J Pediatr Surg. 1996 Dec;31(12):1733-5.

PMID:
8987005
28.

Skin-derived antileukoproteinase (SKALP) is decreased in pustular forms of psoriasis. A clue to the pathogenesis of pustule formation?

Kuijpers AL, Zeeuwen PL, de Jongh GJ, van de Kerkhof PC, Alkemade HA, Schalkwijk J.

Arch Dermatol Res. 1996 Oct;288(11):641-7.

PMID:
8931865
29.

A novel dithranol formulation (Micanol): the effects of monotherapy and UVB combination therapy on epidermal differentiation, proliferation and cutaneous inflammation in psoriasis vulgaris.

Van der Vleuten CJ, Gerritsen MJ, De Jong EM, Elbers M, De Jongh GJ, van de Kerkhof PC.

Acta Derm Venereol. 1996 Sep;76(5):387-91.

PMID:
8891015
30.

Cell kinetic characterization of cultured human keratinocytes from normal and psoriatic individuals.

van Ruissen F, de Jongh GJ, van Erp PE, Boezeman JB, Schalkwijk J.

J Cell Physiol. 1996 Sep;168(3):684-94.

PMID:
8816923
31.

Induction of normal and psoriatic phenotypes in submerged keratinocyte cultures.

Van Ruissen F, de Jongh GJ, Zeeuwen PL, Van Erp PE, Madsen P, Schalkwijk J.

J Cell Physiol. 1996 Aug;168(2):442-52.

PMID:
8707880
32.

Levels of skin-derived antileukoproteinase (SKALP)/elafin in serum correlate with disease activity during treatment of severe psoriasis with cyclosporin A.

Alkemade HA, de Jongh GJ, Arnold WP, van de Kerkhof PC, Schalkwijk J.

J Invest Dermatol. 1995 Feb;104(2):189-93.

33.

SKALP/elafin is an inducible proteinase inhibitor in human epidermal keratinocytes.

Alkemade JA, Molhuizen HO, Ponec M, Kempenaar JA, Zeeuwen PL, de Jongh GJ, van Vlijmen-Willems IM, van Erp PE, van de Kerkhof PC, Schalkwijk J.

J Cell Sci. 1994 Aug;107 ( Pt 8):2335-42.

34.

Cell kinetic characterization of growth arrest in cultured human keratinocytes.

van Ruissen F, van Erp PE, de Jongh GJ, Boezeman JB, van de Kerkhof PC, Schalkwijk J.

J Cell Sci. 1994 Aug;107 ( Pt 8):2219-28.

35.

The growth and differentiation of human keratinocytes in vitro: a combined immunohistochemical and flow cytometric study.

van Erp PE, de Jongh GJ, Boezeman JB, Schalkwijk J.

Arch Dermatol Res. 1994;286(2):115-22.

PMID:
8154924
36.

Cell kinetic characterization of the epidermal growth factor dependent BALB/MK line using flow cytometric analysis of DNA content and iododeoxyuridine incorporation.

van Hooijdonk CA, van Erp PE, Freund RL, de Jongh GJ, Schalkwijk J, van de Kerkhof PC, Mier PD.

Cell Prolif. 1993 Nov;26(6):567-76.

PMID:
9116123
37.

SKALP/elafin: an elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence, and evidence for transglutaminase cross-linking.

Molhuizen HO, Alkemade HA, Zeeuwen PL, de Jongh GJ, Wieringa B, Schalkwijk J.

J Biol Chem. 1993 Jun 5;268(16):12028-32.

38.

Immunohistochemical localization of SKALP/elafin in psoriatic epidermis.

Schalkwijk J, van Vlijmen IM, Alkemade JA, de Jongh GJ.

J Invest Dermatol. 1993 Apr;100(4):390-3.

39.

EGF induces ornithine decarboxylase transcription in Balb/MK keratinocytes: a proposed mechanism for the TGF alpha autocrine loop.

Mier PD, van Hooijdonk CA, Freund RF, de Jongh GJ, van Erp PE, van de Kerkhof PC.

Arch Dermatol Res. 1993;285(4):236-8. No abstract available.

PMID:
8342967
40.

Tenascin expression in basal cell carcinoma.

Verstraeten AA, Mackie EJ, Hageman PC, Hilgers J, Schol DJ, De Jongh GJ, Schalkwijk J.

Br J Dermatol. 1992 Dec;127(6):571-4.

PMID:
1282358
41.

MON-150, a versatile monoclonal antibody against involucrin: characterization and applications.

van Duijnhoven JL, Schalkwijk J, Kranenborg MH, van Vlijmen-Willems IM, Groeneveld A, van Erp PE, Timmer ED, de Jongh GJ, van de Ven WJ.

Arch Dermatol Res. 1992;284(3):167-72.

PMID:
1503502
42.

Skin-derived antileukoproteinase (SKALP), an elastase inhibitor from human keratinocytes. Purification and biochemical properties.

Schalkwijk J, de Roo C, de Jongh GJ.

Biochim Biophys Acta. 1991 Feb 22;1096(2):148-54.

PMID:
2001428
43.

Ratiometric measurement of intracellular pH in cultured human keratinocytes using carboxy-SNARF-1 and flow cytometry.

van Erp PE, Jansen MJ, de Jongh GJ, Boezeman JB, Schalkwijk J.

Cytometry. 1991;12(2):127-32.

44.

Skin-derived antileucoproteases (SKALPs): characterization of two new elastase inhibitors from psoriatic epidermis.

Schalkwijk J, Chang A, Janssen P, De Jongh GJ, Mier PD.

Br J Dermatol. 1990 May;122(5):631-41.

PMID:
2354116
45.
46.

Enzymatic quantification of polymorphonuclear leucocytes in normal and psoriatic skin following standardized injury.

Chang A, de Jongh GJ, Mier PD, van de Kerkhof PC.

Clin Exp Dermatol. 1988 Mar;13(2):62-6. No abstract available.

PMID:
3214957
47.

The lethal effect of longwave ultraviolet light and PUVA. An analysis based upon human mesenchymal cells in vitro.

de Jongh G, Bergers M, Boezeman JB, Verhagen AR, Mier PD.

Photochem Photobiol. 1984 May;39(5):625-9. No abstract available.

PMID:
6739554
48.

Effects of PUVA on human blood monocytes in vitro.

Verhagen AR, Bergers M, de Jongh G, Mier PD.

J Invest Dermatol. 1983 Sep;81(3):201-3.

49.

Response of the clinically uninvolved skin of psoriatic patients to standardized injury.

van de Kerkhof PC, van Rennes H, de Grood RM, de Jongh GJ, Bauer FW, Mier PD.

Br J Dermatol. 1983 Sep;109(3):287-94.

PMID:
6615716

Supplemental Content

Loading ...
Support Center